Vertex Pharmaceuticals
VRTX
#175
Rank
S$151.33 B
Marketcap
S$590.26
Share price
-0.41%
Change (1 day)
-4.76%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$9.77 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are S$9.77 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$8.32 B22.38%
2023-12-31S$6.80 B19.71%
2022-12-31S$5.68 B26.11%
2021-12-31S$4.50 B11.11%
2020-12-31S$4.05 B34.68%
2019-12-31S$3.01 B21.71%
2018-12-31S$2.47 B22.99%
2017-12-31S$2.01 B-10.84%
2016-12-31S$2.25 B13.51%
2015-12-31S$1.98 B21.44%
2014-12-31S$1.63 B34.18%
2013-12-31S$1.21 B-36.21%
2012-12-31S$1.91 B15.72%
2011-12-31S$1.65 B5.01%
2010-12-31S$1.57 B30.45%
2009-12-31S$1.20 B13.73%
2008-12-31S$1.06 B123.22%
2007-12-31S$0.47 B-25.45%
2006-12-31S$0.63 B23.55%
2005-12-31S$0.51 B-38%
2004-12-31S$0.83 B-7.87%
2003-12-31S$0.90 B19.07%
2002-12-31S$0.75 B-8.9%
2001-12-31S$0.83 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
S$48.04 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$176.88 B 1,709.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.61 B 929.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.45 B 937.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$147.13 B 1,405.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
S$0.28 B-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA